Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
HIV Medicine|July 7, 2020
Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohortD Van Beckhoven, E Florence, S De Wit, et al.
Case Reports in Infectious Diseases|November 15, 2024
Rhodococcus equi, an Unusual Human Pathogen That Causes Cavitating Pneumonia in Patients With AIDSJ Vandersnickt, Pee J Van, S Vandamme, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 21, 2014
Syphilis reinfections pose problems for syphilis diagnosis in Antwerp, Belgium - 1992 to 2012C Kenyon, L Lynen, E Florence, et al.
The Journal of Infectious Diseases|October 1, 1996
Immunization with recombinant p17/p24:Ty virus-like particles in human immunodeficiency virus-infected personsJ Veenstra, I G Williams, R Colebunders, et al.
BMC Health Services Research|November 30, 2015
Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern UgandaG Abongomera, S Kiwuwa-Muyingo, P Revill, et al.
HIV Medicine|July 16, 2003
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA studyE Florence, J Lundgren, C Dreezen, et al.
HIV Medicine|February 26, 2015
Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialJ Grarup, C Rappoport, N W Engen, et al.
BMC Infectious Diseases|November 5, 2015
Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrantsD Van Beckhoven, E Florence, J Ruelle, et al.
The Journal of Infectious Diseases|February 13, 1999
Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995Y Guimard, M A Bwaka, R Colebunders, et al.
HIV Medicine|February 26, 2015
Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialE Denning, S Sharma, M Smolskis, et al.
Pageof 20